Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions
This article was originally published in The Tan Sheet
You may also be interested in...
FDA Contests Court Intervention On Plan B As Teva Argues For Exclusivity
In CRR’s lawsuit, FDA and Teva argue that the firm’s potential for OTC market exclusivity for Plan B One-Step should be protected. But while Teva is open to judicial intervention on whether to allow universal OTC sales, FDA says precedent supports judicial deference to agency scientific decisions.
FDA Contests Court Intervention On Plan B As Teva Argues For Exclusivity
In CRR’s lawsuit, FDA and Teva argue that the firm’s potential for OTC market exclusivity for Plan B One-Step should be protected. But while Teva is open to judicial intervention on whether to allow universal OTC sales, FDA says precedent supports judicial deference to agency scientific decisions.
AAP Presses FDA To Eliminate OTC Pediatric Combination Products
The American Academy of Pediatrics wants FDA to eliminate OTC combination pediatric cough/cold products.